Targeted therapy is a type of cancer treatment that focuses on specific proteins or genes that are involved in the growth and survival of cancer cells. In haemato oncology, targeted therapy has become an important treatment option for various types of blood cancers, such as leukemia, lymphoma, and multiple myeloma.
Targeted therapy works by blocking the activity of specific proteins or genes that are involved in cancer growth and survival. This can be done through the use of small molecule inhibitors or monoclonal antibodies. Small molecule inhibitors are drugs that can block the activity of specific proteins inside cancer cells, while monoclonal antibodies are laboratory-made proteins that can attach to specific proteins on cancer cells and block their activity.
Targeted therapy can be used in combination with other treatments, such as chemotherapy or immunotherapy, or as a standalone treatment. The decision to use targeted therapy will depend on various factors, including the type and stage of the cancer, the patient's overall health, and the treatment goals.
Like other cancer treatments, targeted therapy can cause side effects, such as nausea, diarrhea, and skin rash. However, these side effects are usually temporary and can be managed with medication or other supportive therapies.
Overall, targeted therapy has shown promising results in the treatment of various blood cancers, and ongoing research is exploring new ways to use this treatment approach to improve outcomes for patients. At Sterling Hospitals Ahmedabad, our team of hematologists/oncologists is experienced in using targeted therapy to provide personalized treatment options for our patients.